This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Paris Est Creteil Val De Marne. Active years: 2019.
Company Filing History:
1 out of 5,383 
1 out of 1,853 
1 out of 35 
Years Active: 2019
Title: Anthony Ollivier: Innovator in NRF2 Activators
Introduction
Anthony Ollivier is a notable inventor based in Vitry sur Seine, France. He has made significant contributions to the field of medical research, particularly in the development of innovative therapeutic solutions for inflammatory and cardiovascular diseases.
Latest Patents
Ollivier holds a patent for "Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation." This invention relates to highly efficient Nrf2 activators-co-releasing molecules capable of increasing HO-1 protein expression while simultaneously releasing carbon monoxide (CO). The synthesis and therapeutic applications of these molecules are particularly relevant in treating inflammatory or cardiovascular diseases.
Career Highlights
Throughout his career, Anthony Ollivier has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Est Créteil Val de Marne. His work has focused on advancing scientific knowledge and developing practical applications for his inventions.
Collaborations
Ollivier has collaborated with notable colleagues, including Roberto Motterlini and Roberta Foresti, contributing to a rich exchange of ideas and research in his field.
Conclusion
Anthony Ollivier's innovative work in the development of NRF2 activators showcases his commitment to addressing critical health challenges. His contributions to medical research continue to pave the way for new therapeutic strategies.